NeuroScientific Biopharmaceuticals Limited (ASX:NSB)

Market Cap	33.26M +557.1%
Revenue (ttm)	317.91K -85.6%
Net Income	-3.18M
EPS	-0.01
Shares Out	332.58M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	142,936
Average Volume	685,491
Open	0.0990
Previous Close	0.1000
Day's Range	0.0990 - 0.0990
52-Week Range	0.0470 - 0.2600
Beta	1.12
RSI	45.34
Earnings Date	May 26, 2026

About ASX:NSB

NeuroScientific Biopharmaceuticals Limited develops therapeutic treatments for neurodegenerative diseases through preclinical and clinical studies of patented technologies. Its lead drug candidates include EmtinB for treatment of neurodegenerative dementia and Alzheimer's disease, and degenerative conditions of the optic nerve. The company was incorporated in 2002 and is based in Cottesloe, Australia.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2002
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: NSB